Renal Pelvis and Ureter

  • American Joint Committee on Cancer

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.


Renal Pelvis Transitional Cell Carcinoma Urothelial Carcinoma Venous Invasion Lymphatic Vessel Invasion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Al-Abadi H, Nagel R: Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study. J Urol 148(1):31–37, 1992PubMedGoogle Scholar
  2. Anderstrom C, Johansson SL, Pettersson S, et al: Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol 142(2 Pt l):280–283, 1989PubMedGoogle Scholar
  3. Balaji KC, McGuire M, Grotas J, et al: Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol 162:1603–1606, 1999PubMedCrossRefGoogle Scholar
  4. Borgmann V, al-Abadi H, Nagel R: Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter: a study on a follow-up period of 6 years. Urol Int 47(1):7–11, 1991PubMedCrossRefGoogle Scholar
  5. Corrado F, Ferri C, Mannini D, et al: Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 145(6):1159–1163, 1991PubMedGoogle Scholar
  6. Grasso M, Fraiman M, Levine M: Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology 54:240–246, 1999PubMedCrossRefGoogle Scholar
  7. Hall MC, Womack S, Sagalowsky AI, et al: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601, 1998PubMedCrossRefGoogle Scholar
  8. Herr HW: Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 16:1099–1102, 1998PubMedGoogle Scholar
  9. Hisataki T, Miyao N, Masumori N, et al: Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology 55:663–667, 2000PubMedCrossRefGoogle Scholar
  10. Huben RP, Mounzer AM, Murphy GP: Tumor grade and stage as prognostic variables in upper urothelial tumors. Cancer 62(9):2016–2020, 1988PubMedCrossRefGoogle Scholar
  11. Hurle R, Losa A, Manzetti A, Lembo A: Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients. Urology 53:1144–1148, 1999PubMedCrossRefGoogle Scholar
  12. Jabbour ME, Desgrandchamps F, Cazin S, et al: Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 163:1105–1107, 2000PubMedCrossRefGoogle Scholar
  13. Jinza S, Iki M, Noguchi S, et al: Nucleolar organizer regions: a new prognostic factor for upper tract urothelial cancer. J Urol 154(5):1688–1692, 1995PubMedCrossRefGoogle Scholar
  14. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al: Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol 164:1183–1187,2000PubMedCrossRefGoogle Scholar
  15. Scolieri MJ, Paik ML, Brown SL, Resnick MI: Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 56:930–930, 2000PubMedCrossRefGoogle Scholar
  16. Williams RD: Tumors of the kidney, ureter, and bladder. West J Med 56(5):523–534, 1992Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations